ROLE OF BACTERIAL ENDOTOXIN IN CHRONIC HEART FAILURE: THE GUT OF THE MATTER
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Proinflammatory cytokines are now thought to play a key role in the pathophysiology of chronic heart failure, driving both symptomatic presentation and disease progression. We propose that this proinflammatory state, in turn, may be sustained through a chronic release of enterically derived bacterial endotoxin. Human trials have indicated that bacterial decontamination of the gut with concomitant decrease in lipopolysaccharide (LPS) has a positive outcome on heart disease patients. Antiendotoxin antibodies may thus represent therapeutic agents in this setting. Previously, antiendotoxin antibodies were targeted to the inner hydrophobic lipid A moiety of endotoxin in an attempt to neutralize its toxicity. These antibodies failed because they lacked specificity and bound to LPS weakly. In contrast, our studies on antiendotoxin antibodies have revealed that antibodies targeted to the hydrophilic oligosaccharides of the endotoxin have the potential to bind specifically with high affinity. Development of immunotherapeutics that can reduce systemic LPS or other agents, such as bactericidal/permeability-increasing protein that can neutralize LPS and limit inflammation safely, will enable the role of LPS in chronic heart failure to be elucidated and may pave the way to develop a new generation of effective therapeutic agents that may be directed to the treatment of chronic heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 2×
“Low-grade systemic inflammation is a feature of both acute and chronic heart failure (15), with elevation in circulating PIC levels (16), such as TNF-! (17), interleukin (IL)-6 (15), and IL-1 (18), being associated with worsening of symptoms, hospital readmission, and even mortality (19).”
BackgroundElevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582 · cited 1×
“Low-grade systemic inflammation is a feature of both acute and chronic heart failure (15), with elevation in circulating PIC levels (16), such as TNF-! (17), interleukin (IL)-6 (15), and IL-1 (18), being associated with worsening of symptoms, hospital readmission, and even mortality (19).”
BackgroundReceptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442
Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
Rauchhaus, M., Doehner, W., Francis, D. P., Davos, C., Kemp, M., Liebenthal, C., Niebauer, J., Hooper, J., Volk, H.-D., Coats, A. J. S., et al. (2000) · Circulation · doi:10.1161/01.cir.102.25.3060 · Cited by 810
Inflammatory mediators in chronic heart failure: an overview
Anker, S. D., & von Haehling, S. (2004) · Heart · doi:10.1136/hrt.2002.007005 · Cited by 627 · cited 1×
“Low-grade systemic inflammation is a feature of both acute and chronic heart failure (15), with elevation in circulating PIC levels (16), such as TNF-! (17), interleukin (IL)-6 (15), and IL-1 (18), being associated with worsening of symptoms, hospital readmission, and even mortality (19).”
BackgroundWurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure
Anker, S. D., Egerer, K. R., Volk, H.-D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00159-8 · Cited by 392 · cited 2×
“The TNF-! is cardiodepressant through a number of pathways: (1) sphingosine release and suppression of the calcium transient (49, 50); (2) inhibition of the phosphoinositide pathway and of pyruvate dehydrogenase activity that reduces mitochondrial function (51); and (3) enhancing peroxynitrite production and the level…”
BackgroundMunger, M. A., Johnson, B., Amber, I. J., Callahan, K. S., & Gilbert, E. M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89206-5 · Cited by 237
Peschel, T., Schönauer, M., Thiele, H., Anker, S., Schuler, G., & Niebauer, J. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00104-1 · Cited by 187
Cited by
Lucas, K., & Maes, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8425-7 · Cited by 466
“Alternatively, the MyD88-independent pathway via TRAM and TRAF leads to the release of type 1 interferons infection, Parkinson's and Alzheimer's disease, multiple sclerosis, and chronic alcoholism [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] .”
BackgroundTrøseid, M., Ueland, T., Hov, J. R., Svardal, A., Gregersen, I., Dahl, C. P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12328 · Cited by 464
Maes, M., Kubera, M., Leunis, J.-C., & Berk, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.023 · Cited by 446
Abdominal Contributions to Cardiorenal Dysfunction in Congestive Heart Failure
Verbrugge, F. H., Dupont, M., Steels, P., Grieten, L., Malbrain, M., Tang, W. H. W., & Mullens, W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.070 · Cited by 399
Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169
“The chronic release of LPS derived from bacterial translocation may sustain the pro-inflammatory state in CHF (Charalambous et al., 2007).”
Background
Metadata
- Authors
- Charalambous, B. M., Stephens, R. C. M., Feavers, I. M., & Montgomery, H. E.
- Venue
- Shock
- Published
- 2007-07
- Volume
- 28
- Issue
- 1
- Pages
- 15-23
- ISSN
- 1073-2322 (ISSN-L)
- OpenAlex
- W2077026668
- Cited by
- 91
- References
- 10
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ROLE OF BACTERIAL ENDOTOXIN IN CHRONIC HEART FAILURE: THE GUT OF THE MATTER. https://app.cochat.ai/papers/10.1097/shk.0b013e318033ebc5
- The paper
- Charalambous, B. M., Stephens, R. C. M., Feavers, I. M., & Montgomery, H. E. (2007). ROLE OF BACTERIAL ENDOTOXIN IN CHRONIC HEART FAILURE: THE GUT OF THE MATTER. Shock. https://doi.org/10.1097/shk.0b013e318033ebc5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.